Call for Papers: Therapeutic and Abuse-Related Effects of Cannabis and Cannabinoids
Submission Deadline: October 1, 2018
This special issue will provide an overview of current research on cannabis and cannabinoids with an emphasis on issues related to their legalization for medical and recreational use.
We encourage submission of review articles and original research reports in this area, including the following topics:
- Therapeutic efficacy of cannabis and cannabinoids across different disease conditions
- Etiology of cannabinoid use disorders
- Consequences of cannabinoid exposure during pregnancy, adolescence, and adulthood
- Development of forensic testing for detecting acute cannabis intoxication
- Influence of route of cannabinoid administration on therapeutic effects and abuse liability
- Variations in THC content across cannabis strains and cannabinoid-enriched products, and implications for use
- Current federal restrictions on cannabis research
- Prevalence of synthetic cannabinoids, issues with their regulation, mechanisms of action and consequences of their use
- Changes in public perceptions of perceived harm of medicinal and recreational cannabis and cannabinoid use
Researchers in this area may submit review articles or primary research reports to Experimental and Clinical Psychopharmacology to be considered for inclusion in this special issue.
Manuscripts should be submitted as usual through the APA Online Submission Portal, and the cover letter should indicate that the authors wish the manuscript to be considered for publication in the special issue on Therapeutic and Abuse-Related Effects of Cannabis and Cannabinoids.
All submissions will undergo our normal peer review.
Manuscripts received no later than October 1, 2018 will be considered for inclusion in the special issue.
We strongly encourage individuals to contact the guest editors in advance with their ideas and a draft the title and abstract.
Questions or inquiries about the special issue can be directed to the Guest Editors of the issue, Ashley Acheson, PhD, or William Fantegrossi, or the Editor, William Stoops, PhD.